CHARLES L SAWYERS, M.D.
Osteopathic Medicine in New York, NY
License number
New York G58730
Category
Osteopathic Medicine
Type
Hematology & Oncology
License number
New York 241631
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address
1275 York Ave Memorial Sloan-Kettering Cancer Ctr, New York, NY 10021
Phone
(646) 888-2138
(666) 888-2595 (Fax)
(310) 968-4414
(646) 888-2595 (Fax)
(666) 888-2595 (Fax)
(310) 968-4414
(646) 888-2595 (Fax)
Personal information
See more information about CHARLES L SAWYERS at radaris.comName
Address
Phone
40 E 61St St APT 9C, New York, NY 10065
Professional information
Methods Of Identifying And Treating Individuals Exhibiting Complex Karyotypes
US Patent:
2009019, Aug 6, 2009
Filed:
Nov 30, 2006
Appl. No.:
12/085733
Inventors:
Francis Y. Lee - Princeton NJ, US
Charles L. Sawyers - New York NY, US
Neil P. Shah - Mill Valley CA, US
Charles L. Sawyers - New York NY, US
Neil P. Shah - Mill Valley CA, US
International Classification:
A61K 31/496, C12Q 1/68, A61P 35/00, A61P 35/02
US Classification:
51425219, 435 6
Abstract:
The invention described herein relates to diagnostic and therapeutic methods and compositions useful in the management of disorders, for example cancers, involving cells that harbor complex karyotypes. The present invention also related to mutant BCR-ABL kinase proteins, and to diagnostic and therapeutic methods and compositions useful in the management of disorders, for example cancers, involving cells that express such mutant BCR-ABL kinase proteins.
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-Associated Diseases
US Patent:
2013007, Mar 21, 2013
Filed:
Sep 13, 2012
Appl. No.:
13/615085
Inventors:
Michael E. Jung - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Samedy Ouk - Los Angeles CA, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Charles L. Sawyers - New York NY, US
Samedy Ouk - Los Angeles CA, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA - Oakland CA
International Classification:
A61K 31/4439, A61P 35/00, C07D 401/04
US Classification:
514278, 546 15
Abstract:
Described herein, inter alia, are compounds useful for the prevention or treatment of hyperproliferative diseases or disorders.
Androgen Receptor Modulator For The Treatment Of Prostate Cancer And Androgen Receptor-Associated Diseases
US Patent:
8445507, May 21, 2013
Filed:
Mar 27, 2007
Appl. No.:
12/294881
Inventors:
Michael E. Jung - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Samedy Ouk - Los Angeles CA, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Charles L. Sawyers - New York NY, US
Samedy Ouk - Los Angeles CA, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4439, C07D 213/60
US Classification:
514278, 514341, 546 15, 5462741
Abstract:
A hydantoin compound useful for the prevention or treatment of hyperproliferative diseases or disorders.
Treatment Of Hyperproliferative Disorders With Diarylhydantoin Compounds
US Patent:
2012029, Nov 22, 2012
Filed:
Apr 17, 2012
Appl. No.:
13/448964
Inventors:
Charles L. Sawyers - New York NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Los Angeles CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - Rosemead CA, US
John Wongvipat - Arcadia CA, US
Dongwon Yoo - Los Angeles CA, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Los Angeles CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - Rosemead CA, US
John Wongvipat - Arcadia CA, US
Dongwon Yoo - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4184, A61P 35/00, A61K 31/4166
US Classification:
514391
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Treatment Of Hyperproliferative Disorders With Diarylhydantoin Compounds
US Patent:
8183274, May 22, 2012
Filed:
Feb 18, 2010
Appl. No.:
12/708523
Inventors:
Charles L. Sawyers - New York NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Shanghai, CN
Samedy Ouk - Costa Mesa CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Shanghai, CN
Samedy Ouk - Costa Mesa CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4166, A61K 31/4184, C07D 233/86
US Classification:
514391, 5483211, 5483014
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Diarylhydantoin Compounds
US Patent:
2010021, Aug 19, 2010
Filed:
Feb 18, 2010
Appl. No.:
12/708531
Inventors:
Charles L. Sawyers - New York NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Costa Mesa CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Costa Mesa CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/497, C07D 233/86, A61K 31/4166, C07D 401/04, A61K 31/4439, C07D 233/84, C07D 233/76, C07D 471/10, A61K 31/438, C07D 233/88, A61K 31/4164, C07D 241/04, A61P 35/00
US Classification:
51425405, 5483167, 514391, 5483014, 5462741, 514341, 546 20, 514278, 5483215, 514390, 544230
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Diarylthiohydantoin Compounds
US Patent:
8648105, Feb 11, 2014
Filed:
Dec 21, 2011
Appl. No.:
13/333543
Inventors:
Michael E. Jung - Los Angeles CA, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4166, C07D 233/86
US Classification:
514389, 5483014, 5483171
Abstract:
The present invention relates to diarylthiohydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Diarylhydantoin Compounds
US Patent:
2013003, Feb 7, 2013
Filed:
Sep 14, 2012
Appl. No.:
13/619280
Inventors:
Charles L. Sawyers - New York NY, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Costa Mesa CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Dongwon Yoo - Los Angeles CA, US
Michael E. Jung - Los Angeles CA, US
Charlie D. Chen - Los Angeles CA, US
Samedy Ouk - Costa Mesa CA, US
Derek Welsbie - Northridge CA, US
Chris Tran - New York NY, US
John Wongvipat - Nanuet NY, US
Dongwon Yoo - Los Angeles CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
C07D 233/02, C07D 235/02, A61P 35/00, A61K 31/496, C12Q 1/02, A61K 49/00, A61K 31/4166, C07D 403/10
US Classification:
424 92, 5483211, 514391, 5483014, 544370, 51425405, 435 29
Abstract:
The present invention relates to diarylhydantoin compounds, including diarylthiohydantoins, and methods for synthesizing them and using them in the treatment of hormone lefiactory prostate cancer.
Diarylhydantoin Compounds
US Patent:
2009011, Apr 30, 2009
Filed:
Oct 24, 2008
Appl. No.:
12/257743
Inventors:
MICHAEL E. JUNG - Los Angeles CA, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4184, C07D 233/86, C07D 403/10, C07D 235/02, A61K 31/4166
US Classification:
514391, 5483211, 5483144, 5483014
Abstract:
The present invention relates to diarylhydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Diarylthiohydantoin Compounds
US Patent:
8110594, Feb 7, 2012
Filed:
Mar 29, 2007
Appl. No.:
11/730168
Inventors:
Michael E. Jung - Los Angeles CA, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Dongwon Yoo - Los Angeles CA, US
Charles L. Sawyers - New York NY, US
Chris Tran - New York NY, US
John Wongvipat - New York NY, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/4166, C07D 233/86
US Classification:
514391, 5483211, 5483014
Abstract:
The present invention relates to diarylthiohydantoin compounds and methods for synthesizing them and using them in the treatment of hormone refractory prostate cancer.
Osteopathic Medicine licenses in New York
BUSHRA MINA PULMONARY & CRITICAL CARE P. C., Osteopathic Medicine, 155 E 76Th St, New York, NY 10021